Introduction
A previous report (Gharib et al., 1972) describes the occurrence of reduced thyroid function in 4 patients with Addison's disease. The abnormal thyroid chemistry in these patients was corrected by adrenocorticosteroid replacement therapy alone.
The case discussed here shows many of the features of those previously described. The endocrine abnormalities have been established more 
Discussion
The association of myxoedema and Hashimoto's disease in patients with autoimmune Addison's disease (previously termed Schmidt's syndrome) has a reported incidence of about 5% (Nerup, 1974) The suppression of serum TSH and thyroidal iodine release by high dose glucocorticoids in euthyroid and primary hypothyroid subjects has been reported (Wilber and Utiger, 1969; Nicoloff, Fisher and Appleman, 1970) . Withdrawal of maintenance doses of steroids for 48 hr in primary hypoadrenal patients was followed by elevation of both serum TSH and thyroidal iodine release. It was suggested that hydrocortisone may play a prime role in the diurnal rhythms of TSH and thyroid hormones. However, this action of glucocorticoids appears to be a relatively short-term effect. Such an action is not applicable to the patient described here, where restoration of thyroid hormones occurred despite the lowering of plasma TSH, and the effect seems permanent.
Resolution of the hypothyroid biochemistry in this patient occurred despite the presence of antibodies to thyroid microsomes in the serum. Once established, autoimmune thyroid disease is assumed to be a stable or slowly progressive condition, although spontaneous reductions in antibody titre and remissions of goitre can occur. Fluctuations in thyroid antibodies and goitre size related to the more short-term situations of pregnancy and steroid administration have been reported and are relevant to the present case. During pregnancy, circulating antithyroid antibodies decrease and then rise again after delivery (Amino et al., 1978) . It is suggested that immune mechanisms are suppressed by increased steroid production during pregnancy. Large doses of oral cortisone also reduce thyroid antibodies in patients with established Hashimoto's thyroiditis with remission of hypothyroidism (Blizzard et al., 1962) . A decreased thyroid antibody production rate induced by corticosteroids, rather than a modification of the toxic activity of the antibody, seems the likely explanation of the improved thyroid function in these cases. Restoration of physiological corticosteroid concentrations in patients with Addison's disease and concurrent thyroiditis would be expected to have the same result.
A striking clinical feature was the rapid change induced in the patient's diabetic retinopathy after treatment for the hypo-adrenalism. Some of this improvement may be attributed to the response of the anaemia to iron therapy, but it is possible that hormonal influences may also have played a part.
The HLA studies show the presence of HLA B8 haplotype in the patient and 2 of the 3 members of his family investigated. HLA B8 is associated with several organ-specific autoimmune disorders including Addison's disease and hypothyroidism. There is also an association with diabetes mellitus (Cudworth et al, 1979) . In this family both the brothers positive for HLA B8 developed diabetes, although the onset in the propositus was some 14 years earlier. In the patient described above diabetes preceded the development of Addison's disease and temporary thyroid failure, while in his brother diabetes followed Graves' disease. It is difficult to determine whether the diabetes in this family is of the 'primary autoimmune' type (Bottazzo et al., 1978) and related to the polyendocrinopathy, for neither patient had persisting islet cell antibodies which have been suggested as the marker for this group of diabetics.
